Compositions containing alpha-2-adrenergic agonist components
Compositions useful for improving effectiveness of alpha-2-adrenergic agonist components include carrier components, alpha-2-adrenergic agonist components, solubility enhancing components which aid in solubilizing the alpha-2-adrenergic agonist components. In one embodiment, the alpha-2-adrenergic agonist components include alpha-2-adrenergic agonists. In another embodiment, the solubility enhancing components include carboxymethylcellulose.
1. A therapeutically effective aqueous ophthalmic composition for use in reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension comprising:
a solution containing 0.1% (w/v) of a compound selected from the group consisting of brimonidine, a salt of brimonidine, and an ester of brimonidine,
wherein the solution further comprises an oxy-chloro preservative and carboxymethyl cellulose,
wherein the composition has a pH between 7.0-8.0.
2. The composition of claim 1 which comprises about 0.1% (w/v) of brimonidine tartrate.
3. The composition of claim 1 which comprises 0.1% (w/v) of brimonidine tartrate.
4. The composition of claim 3 wherein the carboxymethyl cellulose enhances the solubility of brimonidine tartrate in solution.
5. The composition of claim 3 further comprising boric acid.
6. The composition of claim 3 further comprising sodium borate.
7. The composition of claim 3 further comprising hydrochloric acid.
8. The composition of claim 7 wherein the composition has a pH of 7.4-8.0.